Background-Drug overdose is the leading cause of injury related fatality in the United States, and respiratory failure remains a major source of morbidity and mortality.
Introduction
Drug poisoning accounts for a considerable morbidity, mortality, and health care expenditures worldwide. With nearly 100 deaths per day since 2007, the United States is currently experiencing its worst drug overdose epidemic of all time (1) . According to the CDC, there were approximately 2.5 million drug-related emergency department (ED) visits in 2011 (2) . Even more concerning is that drug overdose is now the leading cause of injury related fatality in the United States, surpassing even motor vehicle collisions (3) .
Respiratory failure from various mechanisms may lead to the requirement of mechanical ventilation, which has historically been a major cause of morbidity and mortality in poisoned patients (4) . Drugs can affect the respiratory system in a number of ways: direct suppression or stimulation of the respiratory center; alteration in the response of chemoreceptors to changes in PCO 2 ; impaired mechanics of respiration from muscular weakness; increase in metabolic demands (e.g. agitation, fever) leading to increased total body oxygen consumption; and creation of acid-base disorders (5) .
Despite the clinical significance, neither the incidence nor risk factors for endotracheal intubation (ETI) in ED patients with suspected overdose are well described. The purpose of this study was to identify the incidence as well as potential risk factors for ETI in this patient population. Additionally, we analyzed variables surrounding ETI that may impact adverse outcomes.
Methods

Study Design and Setting
This study was a secondary analysis of data collected from a prospective cohort of adult ED patients with acute drug overdose at two urban tertiary-care hospitals over a 5-year period (2009-13) (6). These EDs have a combined annual visit volumes in excess of 150,000 and are staffed 24 hours per day with board certified emergency physicians and intensivists. The study protocol was approved by the Institutional Review Board for all participating institutions with a waiver of informed consent.
The screening, inclusion, and exclusion criteria have recently been described elsewhere (6) . Briefly, patients were included who met both of the following criteria: (A) acute presentation (within 24 hours of exposure); and (B) suspected overdose (i.e., illicit drug dose sufficient to cause symptoms or any prescription drug exposure greater than its therapeutic dose). Exclusion criteria were the following: alternative diagnosis (e.g., trauma or infection), chronic presentation (i.e., not meeting acute criteria above), non-drug overdose (e.g., plant), exposures limited to dermal or inhalational means only (i.e., trivial exposures), prisoners, age <18 years, anaphylaxis, patients with incomplete data (i.e., left against medical advice, transferred to an outside institution, or otherwise eloped from the hospital), and patients with do-not-resuscitate orders.
Measurements
Data collection from the medical chart occurred in accordance with accepted guidelines for valid medical chart abstraction, including training of abstractors (blinded to study objectives) and 95% agreement of a random sampling of ten test charts prior to mass data abstraction (8) . While PCC data was used to enhance initial screening/inclusion of subjects, actual medical record data was relied upon for all other data measurements, including study outcomes. ED clinical data included demographics, congestive heart failure (CHF), obstructive lung disease (OLD defined as any one or more of asthma, chronic bronchitis, or emphysema), drug information/screens, and blood gas analysis. Non-respiratory comorbidities (e.g., psychiatric) were not collected as part of the present study.
Outcomes
The study outcome for the current study was endotracheal intubation (ETI) during the hospital or pre-hospital course, defined as placement of an endotracheal tube for the purpose of mechanical ventilation. The original (primary) data analysis for this cohort was adverse cardiovascular events, which has previously been reported (6) . ETI was counted regardless of rapid sequence induction, and excluded non-invasive ventilation. Chart information was recorded regarding indications for ETI, and details of ETI (location, drugs, and procedural complications). In-hospital mortality was also recorded as exploratory secondary outcome.
Study Protocol
Subjects were prospectively followed to hospital discharge with data that included electronic medical records, paper medical records, consult records, and Poison Control Center records (for initial screening/inclusion only, not for data acquisition or outcome data). Hospital medical record follow-up for all patients was performed by research assistants trained in medical abstraction and recorded using standardized data collection forms. Results (from electronic physician notes, laboratory records, radiology results, and discharge summaries) were prospectively available to the study investigators. Patients discharged from the hospital had no further follow-up.
Data Analysis
Sample size was calculated a priori. Assuming a 4% incidence of ETI (based on preliminary data), we calculated the need to analyze 2500 patients to show 150% increased risk from common predictors with an 80% power. We calculated 95% confidence intervals using the estimated standard error method. Normality testing of demographic data (e.g., age) was confirmed using the Shapiro-Wilk test. Chi-squared (with two-tailed Fisher's exact test when appropriate) and t-test were calculated for categorical and continuous variables, respectively, with 5% alpha (2-tailed).
Multivariable logistic regression was built using associations between clinical factors (e.g., past medical history) and the primary outcome, which were first calculated using univariate analysis (p<0.05). Clinically significant covariates with biologically plausible confounding effects, as determined by the study team, were then added to the multivariable regression (SPSS version 21.0, IBM, Chicago, IL), with the exception of individual drug classes/types in an effort to avoid over-fitting the regression model. Regression model fit was assessed by the Nagelkerke method with R 2 statistics. Missing data was handled by listwise deletion. Multicollinearity was assessed using the Variance Inflation Factor (VIF). No interaction terms were introduced.
Results
Main Results
Patient screening and final inclusion of 2,497 patients analyzed for this study is summarized in Figure 1 . Basic demographics of the study population are listed in Table 1 . Of these, there were 87 who underwent ETI, thus the incidence of ETI was 3.5%. Univariate (unadjusted) risk factors for ETI included age (mean difference −3.6 years, CI −7.4 to −0.2) and history of OLD; neither gender nor CHF were associated with ETI. Drug exposures significantly associated with ETI included opioids followed by benzodiazepines and sedative-hypnotics. Table 2 lists the indications for ETI, the most common of which was perceived worsening of clinical course.
Multivariable Regression Model
We derived independent risk factors for ETI using multivariable logistic regression, summarized in Table 3 . After controlling for confounders (gender, site), younger age (adjusted OR 0.97, CI 0.96-0.98, or 3% decreased odds for each year over 18) and OLD (adjusted OR 6.6, CI 3.5-12.3) were found to be independent predictors of ETI risk.
Blood Gas Analysis
In the entire cohort, mortality was associated with lower mean pH (7.15 vs 7.36) and higher mean PCO 2 (68 vs. 48 mmHg) as outlined in Table 4 . In subsequent analysis of just the OLD subgroup, we found that these patients had a significantly higher PCO 2 (54.6 vs. 47.9 mmHg, p<0.01) and lower pH (7.31 vs. 7.36, p<0.01) than non-OLD patients ( Table 4) . Using a PCO2 cutoff of 60 mmHg had a negative and positive predictive value for mortality of 99.4% (98.8-99.8) and 6.0% (CI 2.8-11.2), respectively.
Rapid Sequence Intubation (RSI)
ETI performance sites were pre-hospital (N=16), the ED (N=58), and the ICU (N=13). The most commonly used induction agents for ETI were etomidate, followed by propofol and ketamine ( Table 5 ). Rocuronium was the paralytic of choice for 34% of ETI, 29% used succinylcholine, while 22% documented no use of a paralytic. Pre-hospital ETI was associated with increased risk of mortality (OR 2.0) compared with ED and inpatient ETI, however this finding did not achieve significance. Early complications of ETI included uncommon desaturation (3.4%) and rare bradycardia (1%). There was a significant association between in-hospital fatality and lack of use of either a sedative (OR 8.6, CI 2.1-34.9) or paralytic (OR 7.5, CI 1.9-3.1) for RSI.
Discussion
The main findings of this study were that younger age and a prior history of obstructive lung disease are associated with ETI in acute overdose patients, implying that they are more at risk for respiratory failure following overdose. Furthermore, drug exposures also had several associations with ETI risk. As expected, the patients with OLD had a higher PCO 2 and a lower pH than those without OLD. We also found that failure to use of a sedative and/or paralytic for RSI was associated with significantly increased odds of in-hospital mortality.
Currently, there is no established consensus or guideline for when an overdose patient requires ETI. It has been suggested that the Glasgow Coma Scale (GCS) may be useful in guiding the requirement for endotracheal intubation, as a patient with decreased consciousness and loss of protective airway reflexes may be predisposed to respiratory failure and aspiration injury (9-10). However, the correlation between the GCS score and the risk of aspiration is poor (11) (12) . Additionally, previous studies have shown that patients with a decreased GCS score may be safely observed and does not mandate endotracheal intubation (9, 13) . Therefore, this study aimed to explore other risk factors that may be associated with respiratory failure and ETI.
We found an interesting association between ETI risk and age. Initially with univariate analysis, there was suggestion of increased risk with increased age; however, in the more conclusive multivariable model, older age was protective with a 3% decreased odds of ETI for every year over age 18 (i.e., the youngest age meeting study inclusion criteria). From a statistical standpoint, this change is explained by the effect of confounding variables on the association between age and ETI. Confounding was controlled in the model (i.e., gender, hospital site, and OLD), and the true effect of decreased risk with increasing age was uncovered. From a clinical standpoint, there are several possible explanations. Younger patients may display higher risk-taking behaviors (14) , and be more prone to severe drug overdose by virtue of lack of experience, or may be associated with psychiatric comorbidities prevalent at younger ages, such as attention deficit hyperactivity disorder (15) . Alternatively, drugs with prominent respiratory depression such as opioids and sedativehypnotics may be more prevalent in select younger age groups (16) . The full clinical implications of this association are unclear from the current study and require further investigation.
In our secondary analysis of blood gas data, we found a lower pH and higher PCO 2 in OLD patients. While this may seem intuitive, it may actually be useful information to obtain in this population, especially early in the care of a patient who may be obtunded or provide a limited history (e.g., due to suicidality). This finding is consistent with a study conducted by Donald et al. regarding associations with ETI, which found a higher pre-intubation PCO 2 in overdose patients (17) . Approximately 2-4% of patients who are hospitalized for an acute exacerbation of asthma will require mechanical ventilatory support (18) ; however, the majority of hypercapnic asthma patients do not require intubation (19) . Our findings add to this data, and further indicate that PCO 2 monitoring may be an early predictor of the need for intubation in the overdose population.
Our study found that the early complication rate for ETI was very low overall. However, prehospital endotracheal intubation was loosely associated with increased mortality compared with ED and inpatient ETI. This may be explained by confounding of pre-hospital cardiac arrest. Interestingly, the results demonstrated highly increased odds of mortality for the ETI cases that had no sedative and/or no paralytic compared to those who were intubated with medications. A previous study, by Adnet et al., demonstrated that in poisoned patients, intubations with etomidate but without neuromuscular blockade were more technically difficult (20) . Their results suggested that RSI should result in better conditions for ETI in poisoned patients. A separate study, also by Adnet et al., showed that patients with a GCS score between 7-9 had the highest rate of difficulties during intubation (21) . Our finding of higher mortality in patients without any sedative/paralytic may be a reflection of the fact that RSI enhances the care of the patient, or possibly may be a marker for higher quality of care. Alternatively, it may be that these patients were more seriously poisoned and required a "crash" intubation which may explain the higher mortality.
Clinically, the results of this study may be applicable to the initial ED approach to the poisoned patient. Screening for high-risk co-morbidities and demographics (i.e., age and OLD) may be useful for early risk stratification of airway management. The results also suggest a potential role for end tidal CO 2 monitoring in overdose patients, since capnography would allow for an estimation of the PaCO 2 based on the waveform displayed on an end tidal monitor (22) . As the current protocol did not include routine capnography, future studies should evaluate systematic use of end-tidal CO 2 monitoring to allow for potentially earlier identification of overdose patients at risk for respiratory failure.
Limitations
The design of this study as a secondary data analysis may have limited the interpretation of the reason for respiratory failure; therefore, we used simply ETI as our study outcome, rather than "respiratory failure". Exposure confirmation through analytical testing was lacking in a subset of patients, however suspicion of overdose based on history, clinical findings, or ancillary testing was documented by healthcare providers in all cases. Timing of blood gas measurement could not be standardized as this was an observational study; thus our blood gas data are hypothesis-generating only, and require further validation. There were no set criteria for ETI of poisoned patients and each case was subject to the individual physician's clinical judgment; unfortunately clustering by provider was not possible. Additionally, both study centers in this study were urban teaching hospitals, and the results may or may not be generalizable to rural or community settings. Finally, future studies should include a larger sample size, given the low rate of ETI for acutely poisoned patients and the even lower rate of early complications from ETI.
Conclusions
ETI was infrequently performed for ED patients with acute drug overdose; when it was performed, complications were rare. Age and prior obstructive lung disease were derived as independent clinical risk factors for ETI in this study population. Clinicians should be aware of these high risk features during the initial ED approach to the poisoned patient. Indications for ETI were adapted from the heuristics developed by Walls and colleagues [23] , and based on the documented procedure note or progress note. Many patients met more than one indication for intubation.
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